Literature DB >> 28385084

Iron in deep brain nuclei in migraine? CAMERA follow-up MRI findings.

Inge H Palm-Meinders1, Hille Koppen2,3, Gisela M Terwindt2, Lenore J Launer4, Mark A van Buchem1, Michel D Ferrari2, Mark C Kruit1.   

Abstract

Introduction In the CAMERA population-based MRI study, migraineurs below the age of 50 had decreased T2-values indicative of increased iron deposition in several deep brain nuclei. Longer migraine history was associated with lower T2-values, suggesting an association between migraine attacks and iron accumulation. In the present nine-year follow-up study of the CAMERA cohort we re-measured the T2-values in deep brain nuclei to assess the evolution over time. Methods Baseline and follow-up T2-values measured in several basal ganglia of 128 participants (38 control, 90 migraine) were analyzed using quantitative T2 measurements and multivariate regression analysis. Results T2-values of most deep brain nuclei were increased - instead of an expected further decrease when only age-related iron accumulation would have played a role - compared to baseline (both among controls and migraineurs) and were not different in either group. In migraineurs, no differences were found by gender, migraine severity or subtype. Conclusion This study did not provide supportive data for migraine related increased iron accumulation in deep brain nuclei, but neither is it able to reject such hypotheses. Increased T2-values probably point at microstructural tissue changes that counteracted earlier accumulated iron effects. We hypothesize that, with aging, migraine-induced iron-related brain changes are obscured by other age-related tissue changes.

Entities:  

Keywords:  CAMERA; MRI; Migraine; T2-value; brain; iron

Mesh:

Substances:

Year:  2017        PMID: 28385084      PMCID: PMC5545876          DOI: 10.1177/0333102416668654

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  14 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

Review 2.  Imaging iron stores in the brain using magnetic resonance imaging.

Authors:  E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus
Journal:  Magn Reson Imaging       Date:  2005-01       Impact factor: 2.546

3.  Volume and iron content in basal ganglia and thalamus.

Authors:  Patrice Péran; Andrea Cherubini; Giacomo Luccichenti; Gisela Hagberg; Jean-François Démonet; Olivier Rascol; Pierre Celsis; Carlo Caltagirone; Gianfranco Spalletta; Umberto Sabatini
Journal:  Hum Brain Mapp       Date:  2009-08       Impact factor: 5.038

4.  Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects.

Authors:  Domenico Aquino; Alberto Bizzi; Marina Grisoli; Barbara Garavaglia; Maria Grazia Bruzzone; Nardo Nardocci; Mario Savoiardo; Luisa Chiapparini
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

5.  MR evaluation of age-related increase of brain iron in young adult and older normal males.

Authors:  G Bartzokis; M Beckson; D B Hance; P Marx; J A Foster; S R Marder
Journal:  Magn Reson Imaging       Date:  1997       Impact factor: 2.546

6.  MRI of brain iron.

Authors:  B Drayer; P Burger; R Darwin; S Riederer; R Herfkens; G A Johnson
Journal:  AJR Am J Roentgenol       Date:  1986-07       Impact factor: 3.959

7.  Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?

Authors:  K M Welch; V Nagesh; S K Aurora; N Gelman
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

Review 8.  Role of different brain areas in peripheral nerve injury-induced neuropathic pain.

Authors:  Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Brain Res       Date:  2011-01-14       Impact factor: 3.252

9.  Structural brain changes in migraine.

Authors:  Inge H Palm-Meinders; Hille Koppen; Gisela M Terwindt; Lenore J Launer; Junya Konishi; Juliette M E Moonen; Jacobus T N Bakkers; Paul A M Hofman; Baldur van Lew; Huub A M Middelkoop; Mark A van Buchem; Michel D Ferrari; Mark C Kruit
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

10.  Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI.

Authors:  Andrea Cherubini; Patrice Péran; Carlo Caltagirone; Umberto Sabatini; Gianfranco Spalletta
Journal:  Neuroimage       Date:  2009-06-21       Impact factor: 6.556

View more
  5 in total

1.  Is There Any Correlation between Migraine Attacks and Iron Deficiency Anemia? A Case-Control Study.

Authors:  Ali Tayyebi; Maryam Poursadeghfard; Masoumeh Nazeri; Tahereh Pousadeghfard
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2019-07-01

2.  The increased iron deposition of the gray matter over the whole brain in chronic migraine: An exploratory quantitative susceptibility mapping study.

Authors:  Zhiye Chen; He Zhao; Xiaoyan Chen; Mengqi Liu; Xin Li; Lin Ma; Shengyuan Yu
Journal:  Mol Pain       Date:  2022 Jan-Dec       Impact factor: 3.395

3.  Voxel-based quantitative susceptibility mapping revealed increased cerebral iron over the whole brain in chronic migraine.

Authors:  Zhiye Chen; Wei Dai; Xiaoyan Chen; Mengqi Liu; Lin Ma; Shengyuan Yu
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

4.  Iron Deposits in Periaqueductal Gray Matter Are Associated with Poor Response to OnabotulinumtoxinA in Chronic Migraine.

Authors:  Clara Domínguez Vivero; Yago Leira; Marta Saavedra Piñeiro; Xiana Rodríguez-Osorio; Pedro Ramos-Cabrer; Carmen Villalba Martín; Tomás Sobrino; Francisco Campos; José Castillo; Rogelio Leira
Journal:  Toxins (Basel)       Date:  2020-07-28       Impact factor: 4.546

5.  Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache.

Authors:  Maria Papasavva; Michail Vikelis; Martha-Spyridoula Katsarou; Vasileios Siokas; Emmanouil Dermitzakis; Christoforos Papademetriou; Konstantinos Karakostis; George Lazopoulos; Efthimios Dardiotis; Nikolaos Drakoulis
Journal:  J Mol Neurosci       Date:  2021-09-27       Impact factor: 3.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.